NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework ()
- Duration
- not specified
- Value
- £321M
- Sector
- MISCELLANEOUS
- Published
- 18 Dec 2025
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
Geochart for 1 buyers and 7 suppliers
1 buyer
- NHS England London
7 suppliers
- Aventis Pharma Reading
- Northumbria Pharma Sedgefield
- Pfizer Kent
- Rovi Biotech Bromley
- Techdow Pharma England Guildford
- Venipharm London
- Viatris UK Healthcare Potters Bar
Description
NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/25/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Award Detail
| 1 | Aventis Pharma (Reading)
|
| 2 | Northumbria Pharma (Sedgefield)
|
| 3 | Pfizer (Kent)
|
| 4 | Rovi Biotech (Bromley)
|
| 5 | Techdow Pharma England (Guildford)
|
| 6 | Venipharm (London)
|
| 7 | Viatris UK Healthcare (Potters Bar)
|
CPV Codes
- None found
Indicators
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-05838e
- FTS 084259-2025